Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1 1

Status

Completed 5Unknown 3Terminated 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 1Dermatologic 1

Conditions

Breast Neoplasms 2Parasomnias 1Depression 1Breast Cancer - Female 1Anxiety Disorders 1

Interventions

Trastuzumab 87Cyclophosphamide 67Capecitabine 67Paclitaxel 64Docetaxel 58Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 41Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 19atezolizumab 18pertuzumab 17Everolimus 17130-nm albumin-bound paclitaxel 17Epirubicin 16palbociclib 15Magnetic Resonance Spectroscopy 15eribulin 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Melatonin × Breast × Clear all
NCT02332928 2023-03-30

Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy

Virginia Commonwealth University

Phase 3 Terminated
80 enrolled 15 charts
Breast

Breast Cancer - Female

NCT01355523 2014-05-06

MELODY

Herlev Hospital

Phase 2/3 Terminated
54 enrolled 27 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias

NCT00506064 2012-12-05

Melatonin Postoperative Sleep Study in Breast Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled 2 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡